View Older Stories View More Recent Stories
-
Aztec Engages Kappes, Cassiday & Associates to Advance Metallurgical Testing of Oxide Gold-Silver Mineralization at Tombstone
-
NXT Energy Solutions Announces New Director
-
IRS Form 2290 Filing Window Now Open for 2026-27 Tax Period; Stay HVUT Compliant with EZ2290
-
Tiny Chief Executive Officer Adopts Automatic Share Purchase Plan
-
Athena Gold Completes Maiden Drill Program at Laird Lake Project in Ontario's Red Lake Gold District
-
Rosenblatt keeps CoreWeave (CRWV) at Buy following Meta AI rumor
-
Needham Upgrades Silicom Ltd. (SILC) to Buy
-
Clarivate Analytics (CCC) Reiterated at Buy by Stifel: 'Should be Standing as a Winner'
-
Levi Strauss & Co. (LEVI) PT Raised to $32 at JPMorgan
-
Alzai Health Corp. Signs Strategic U.S. Commercialization Agreement with Centauri Health Solutions to Advance AI-Driven Alzheimer's Risk Identification
-
Guggenheim Reiterates Buy Rating on Kroger (KR)
-
Canaccord Starts Infleqtion, Inc (INFQ) at Buy
-
H.C. Wainwright Assumes Larimar Therapeutics (LRMR) at Buy
-
Goldman's Garrett sees investors dialing back tech exposure into H2
-
Lindsay (LNN) Tops Q3 EPS by 18c, Misses on Revenue
-
Jacobs named owner's engineer for 288MW wind farm in Australia
-
Eaton reports 40% GHG emissions cut, $2.1B in R&D spending
-
Ring Energy cuts debt by $66M, lifts liquidity to $226M
-
Roth/MKM Starts JFB Construction (JFB) at Buy
-
H.C. Wainwright Reiterates Buy Rating on Medicenna Therapeutics (MDNA)
-
H.C. Wainwright Reiterates Buy Rating on MindWalk Holdings (HYFT)
-
H.C. Wainwright Reiterates Buy Rating on Brainsway (BWAY)
-
H.C. Wainwright Reiterates Buy Rating on Arrowhead Pharma (ARWR)
-
H.C. Wainwright Reiterates Buy Rating on Exelixis (EXEL)
-
Can-Fite BioPharma (CANF) PT Raised to $8 at H.C. Wainwright
-
Genmab A/S (GMAB) PT Raised to $40 at H.C. Wainwright
-
Wallbox raises ~€15.8M through equity and new investor
-
Antalpha Platform Holding Company (ANTA) files $100M mixed shelf
-
Mizuho Reiterates Neutral Rating on Valero Energy (VLO)
-
Mizuho Reiterates Outperform Rating on EQT Corp. (EQT)
-
Mizuho Reiterates Neutral Rating on EOG Resources (EOG)
-
PBCN drops legal challenge, backs Denison Mines uranium project
-
Phase 1 Metallurgical Results Show Broad Cyanide Response at Volcan
-
GFL Environmental (GFL) Declares $0.0169 Quarterly Dividend; 0.2% Yield
-
Lithuania moves to lift constitutional ban on nuclear weapons
-
BTIG Reiterates Buy Rating on Caris Life Sciences Inc (CAI)
-
Wolfe Research Upgrades Chevron (CVX) to Outperform (Yesterday)
-
Coca-Cola Europacific Partners launches second €500mn share buyback tranche
-
DA Davidson Downgrades eXp World Holdings (AGNT) to Neutral
-
Constellation Brands (STZ) PT Lowered to $139 at Barclays
-
Ryanair June traffic reaches record 21.2 million passengers
-
Pepsico (PEP) PT Lowered to $144 at Barclays
-
Airbus wins contract to build Aeolus-2 weather satellite for ESA
-
Hacker Interstellar files for Nasdaq IPO at up to $11.50 per share
-
Ouster (OUST) files mixed shelf
-
DA Davidson Upgrades Palantir (PLTR) to Buy, 'A Gift for Our Nation's 250th Birthday'
-
Novartis wins EU approval for SMA gene therapy in older patients
-
BTIG on Take-Two Interactive (TTWO): 'we think Take Two may have captured ~15-22M initial pre-orders'
-
Array Technologies (ARRY) PT Lowered to $10 at Jefferies, 'Playing Offense Amid Preferred Anxiety'
-
BofA Securities Starts Clearwater Paper (CLW) at Neutral
